Clinical Trial: Schizophrenic Patients Taking Part in Integrated Care Program
Study Status: Terminated
Recruit Status: Terminated
Study Type: Observational
Official Title: Evaluation of Treatment Outcomes in Schizophrenic Patients Taking Part in the Integrated Care Program - a Single-country, Multi-centre Non-interventional Study
Brief Summary: Purpose of this non-interventional study (NIS) is to assess the effect of the participation in an integrated care program on treatment outcomes in patients treated with Seroquel for schizophrenia.
Detailed Summary:
Sponsor: AstraZeneca
Current Primary Outcome: Subjective Well-Being measured via SWN patient questionnaire [ Time Frame: 6 month period of observation,4 assessments ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Quality of Life and patient`s satisfaction measured by Q-LES-Q-18 and CSQ-8 [ Time Frame: 6 month period of observation, 1 assessment at end of NIS ]
- Symptomatic and functional outcome measured by CGI-S, PANSS-8, GAF, EQ-5D and VOI [ Time Frame: 6 month period of observation, 4 assesments ]
- Compliance and health economic aspects measured by MARS, days of hospitalization, productivity loss [ Time Frame: 6 month period of observation, 4 assesments ]
Original Secondary Outcome: Same as current
Information By: AstraZeneca
Dates:
Date Received: February 5, 2008
Date Started: January 2008
Date Completion:
Last Updated: December 8, 2010
Last Verified: October 2008
